Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service
Provided By GlobeNewswire
Last update: Aug 7, 2025
FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient outcomes
Read more at globenewswire.com
